A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages.

Alzheimer’s disease blood-based biomarker conformation variant of p53 machine learning β-amyloid

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
26 Dec 2020
Historique:
received: 20 11 2020
revised: 22 12 2020
accepted: 24 12 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

Early diagnosis of Alzheimer's disease (AD) is a crucial starting point in disease management. Blood-based biomarkers could represent a considerable advantage in providing AD-risk information in primary care settings. Here, we report new data for a relatively unknown blood-based biomarker that holds promise for AD diagnosis. We evaluate a p53-misfolding conformation recognized by the antibody 2D3A8, also named Unfolded p53 (U-p53

Identifiants

pubmed: 33375220
pii: jpm11010014
doi: 10.3390/jpm11010014
pmc: PMC7823360
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : DIADEM s.r.l.
ID : to D.U.
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : to D.U. and M.Me

Références

Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
N Engl J Med. 2014 Apr 10;370(15):1460
pubmed: 24716687
JAMA. 2009 Jul 22;302(4):385-93
pubmed: 19622817
Mol Psychiatry. 2008 Jun;13(6):641-7
pubmed: 17684496
PLoS One. 2012;7(1):e29789
pubmed: 22242180
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Aging Cell. 2015 Aug;14(4):595-604
pubmed: 25773675
Sci Rep. 2019 Sep 20;9(1):13622
pubmed: 31541187
Neurology. 2019 Oct 22;93(17):e1647-e1659
pubmed: 31371569
Cell Death Differ. 2016 Sep 1;23(9):1515-28
pubmed: 27104929
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Sci Rep. 2017 Sep 5;7(1):10528
pubmed: 28874808
Curr Alzheimer Res. 2017;14(1):112-122
pubmed: 27748187
J Neuroimmunol. 2003 Feb;135(1-2):29-37
pubmed: 12576221
Eur J Neurol. 2010 Oct;17(10):1236-48
pubmed: 20831773
Mech Ageing Dev. 2020 Dec;192:111385
pubmed: 33129798
Lancet Neurol. 2004 Apr;3(4):246-8
pubmed: 15039037
J Alzheimers Dis. 2010;20(1):97-104
pubmed: 20164600
Alzheimers Dement (N Y). 2017 May 24;3(3):367-384
pubmed: 29067343
Alzheimers Dement. 2011 Jul;7(4):386-395.e6
pubmed: 21784349
Am J Pathol. 2002 Jan;160(1):123-30
pubmed: 11786406
Nat Rev Neurol. 2017 Nov;13(11):703
pubmed: 29027541
Alzheimers Dement. 2017 Jan;13(1):45-58
pubmed: 27870940
Arch Neurol. 2001 Nov;58(11):1803-9
pubmed: 11708987
Alzheimers Res Ther. 2020 Dec 3;12(1):160
pubmed: 33272326
Nat Rev Neurol. 2018 Nov;14(11):639-652
pubmed: 30297701
Nucleic Acids Res. 2007;35(22):7475-84
pubmed: 17942417
Aging Clin Exp Res. 2017 Dec;29(6):1173-1179
pubmed: 28211026
PLoS One. 2010 Apr 14;5(4):e10171
pubmed: 20418953
Prog Neurobiol. 2018 Sep;168:104-127
pubmed: 29733887
Free Radic Biol Med. 2018 Dec;129:430-439
pubmed: 30321702
Genes Cancer. 2011 Apr;2(4):443-52
pubmed: 21779512
Nat Cell Biol. 2008 Jun;10(6):676-87
pubmed: 18454141
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Free Radic Biol Med. 2012 May 1;52(9):1727-33
pubmed: 22387179
Biochem Pharmacol. 2000 Jan 1;59(1):25-33
pubmed: 10605931
Cell Biosci. 2013 Feb 06;3(1):9
pubmed: 23388203
Nature. 2018 Feb 8;554(7691):249-254
pubmed: 29420472
J Cell Sci. 2002 Aug 1;115(Pt 15):3131-8
pubmed: 12118068
J Intern Med. 2016 Jun;279(6):576-91
pubmed: 26940242
Neurodegener Dis. 2010;7(1-3):50-5
pubmed: 20160459
Sci Rep. 2019 Nov 22;9(1):17347
pubmed: 31758050
EMBO J. 2006 Sep 6;25(17):4084-96
pubmed: 16946709
BMC Geriatr. 2013 Sep 24;13:98
pubmed: 24063518
Nat Med. 2005 Dec;11(12):1306-13
pubmed: 16286925
Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):13-18
pubmed: 28030437
Subcell Biochem. 2014;85:337-58
pubmed: 25201203

Auteurs

Giulia Abate (G)

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

Marika Vezzoli (M)

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

Letizia Polito (L)

GolgiCenci Foundation, 20081 Abbiategrasso, Italy.

Antonio Guaita (A)

GolgiCenci Foundation, 20081 Abbiategrasso, Italy.

Diego Albani (D)

Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", 20156 Milan, Italy.

Moira Marizzoni (M)

Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.

Emirena Garrafa (E)

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

Alessandra Marengoni (A)

Department of Clinical and Experimental Sciences, University of Brescia, Lombardy, 25123 Brescia, Italy.

Gianluigi Forloni (G)

Department of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", 20156 Milan, Italy.

Giovanni B Frisoni (GB)

Memory Clinic, University Hospitals and University of Geneva, 1205 Geneva, Switzerland.

Jeffrey L Cummings (JL)

Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV) and Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV 89106, USA.

Maurizio Memo (M)

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.

Daniela Uberti (D)

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.

Classifications MeSH